Skip to Content

'
Haesun Choi, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Haesun Choi joined MD Anderson Cancer Center in 1999 as a clinical radiologist. She is specialized in body MRI and CT. Her clinical experience is focused on male and female pelvic MRI, including the prostate, uterus, cervix and rectum, liver imaging, functional MRI including dynamic contrast enhanced (DCE) - MRI, DWI and spectroscopy (MRS). She has extensive clinical experience on prostate MRI parallels with building up a highly successful prostate imaging program at MD Anderson Cancer Center.

Over the last 10 years, Dr. Choi has been involved in the development and application of the non-invasive methods for liver fat and iron quatitaion and evaluation of the underlying liver fibrosis and hepatocellular carcinoma. Dr. Choi believes that as an oncologic radiologist, one of the most important contributions in research as well as clinical patient care, is provision of accurate and reliable measures of tumor response, which has lead to develop the so called "Choi Criteria".

Research Interests

Prostate Imaging
Liver Imaging
GIST
MRS


Clinical Interests

MRI
CT
DCE MRI
DWI
MRS

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler Street
Department of Radiology
Unit Number: 1473
Houston, TX 77030
Room Number: FCT15.6084

Education & Training

Degree-Granting Education

1979 Hanyang University, Seoul, Korea, Republic of, MD, Medicine

Postgraduate Training

1989-1991 Fellowship, Diagnostic Imaging (CT, US, MRI), The University of Texas MD Anderson Cancer Center, Houston, TX
1987-1989 Resident, Diagnostic Radiology, University of South Alabama Medical Center, Mobile, AL
1984-1987 Resident, Nuclear Medicine, University of Iowa Hospitals, Iowa City, IA

Board Certifications

1990 American Board of Radiology
1987 American Board of Nuclear Medicine

Experience/Service

Academic Appointments

Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999-2002

Other Appointments/Responsibilities

Visiting Professor, Graduate School of Cancer Science and Policy, National Cancer Center, Seoul, Korea, Republic of, 2015-present
ACRIN representative, Eastern Cooperative Oncology Group (ECOG), Philadelphia, PA, 2014-present
NCI - NET Task Force Member, ACRIN representative to the Neuroendocrine Tumor (NET) Task Force (TF) of the Gastrointestinal Steering Committee (GISC); National Cancer Institute (NCI), Bethesda, MD, 2014-present
Imaging Committee Member, Southwest Oncology Group (SWOG) Imaging Committee, San Antonio, TX, 2013-present
Investigator (I-52833), Cancer Therapy Investigator Program (CTEP), NCI, Bethesda, MD, 2013-2016
Board Member, Gastrointestinal Stromal Tumors Global Strategic Advisory Board, Novartis Oncology, Basel, Switzerland, 2004-present
Core Faculty, Gastrointestinal Stromal Tumors Continuing Medical Education (CME) Visiting Faculty Program, Health Science Center for CME, New York City, NY, 2004-present

Professional Memberships

American Roentgen Ray Society
Member, 1991-present
Connective Tissue Oncology Society
Board of Directors, 2005-2008
Member, 2004-present
International Society of Magnetic Resonance Imaging
Member, 2003-present
Korean Association of Internal Medicine
Member, 1983-present
Korean Medical Association
Member, 1979-present
North American Neuro Endocrine Tumor Society, Vancouver, WA
Member, 2013-present
Radiological Society of North America
Member, 1987-present
Society of Nuclear Medicine
Member, 1984-present
Southwest Oncology Group, San Antonio, TX
Member, 2013-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography (CT) and positron emission tomography (PET) in patients with metastatic GIST treated at a single institution with imatinib mesylate: proposal of new CT response criteria. J Clin Oncol 25(13):1753-1759, 2007. PMID: 17470865.
2. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol 25(13):1760-1764, 2007. PMID: 17470866.
3. Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist 13 Suppl 2:4-7, 2008. PMID: 18434631.
4. Weinreb J C, Blume D, Coakley F V, Wheeler T M, Cormack J B, Sotto C K, Choi H, Kawashima A, Tempany-Afdahl C M, Macura K J, Rosen M, Gerst S R, Kurhanewicz J. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 251(1):122-133, 2009.
5. Choi H. Imaging modalities of gastrointestinal stromal tumors. J Surg Oncol 104(8):907-914, 12/2011. PMID: 22069176.
6. Boonsirikamchai P, Kaur H, Kuban DA, Jackson E, Hou P, Choi H. Use of maximum slope images generated from dynamic contrast-enhanced magnetic resonance imaging to detect locally recurrent prostate carcinoma following prostatectomy - a practical approach. AJR Am J Roentgenol 198(3):W228-236, 3/2012. PMID: 22358019.
7. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32(2):389-409, 3/2012. PMID: 22411939.
8. Hou P, Popat UR, Lindsay RJ, Jackson EF, Choi H. A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique. Radiol Res Pract 2012:207391, 2012. e-Pub 12/2012. PMCID: PMC3530181.
9. Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H. MR imaging of prostate cancer in radiation oncology: what radiologists need to know. Radiographics 33(3):741-61, 5/2013. PMID: 23674772.
10. Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 5(3):126-42, 3/2013. PMCID: PMC3650203.
11. Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 10/2013. PMID: 24059396.
12. Rauch GM, Kaur H, Choi H, Ernst RD, Klopp AH, Boonsirikamchai P, Westin SN, Marcal LP. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer. Radiographics 34(4):1082-98, Jul-Aug, 7/2014. PMID: 25019443.
13. Choi H, Underwood M, Boonsirikamchai P, Matin S, Troncoso P, Ma J. Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience. Quant Imaging Med Surg 4(4):251-8, 8/2014. PMCID: PMC4137178.
14. Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, Koh DM, Raman S, Gee M, Choi H, Landrum L, Mannel R, Chuang L, Yu JQ, McCourt CK, Gold M. Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233. European J Radiol Open 2:11-18, 2015. PMCID: PMC4357172.

Last updated: 6/11/2015